Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jennifer Gjerde
A Randomized Phase II Presurgical Trial of Weekly Low-Dose Tamoxifen Versus Raloxifene Versus Placebo in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in McF-7 Breast Cancer Cells
PLoS ONE
Multidisciplinary
Related publications
Medical Oncologists’ Perception of Anti-Estrogen Therapy Benefit in Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Dicer Expression in Estrogen Receptor–positive Versus Triple-Negative Breast Cancer: An Antibody Comparison
Human Pathology
Forensic Medicine
Pathology
Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Raptor Localization Predicts Prognosis and Tamoxifen Response in Estrogen Receptor-Positive Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer
Oncotarget
Oncology
Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia
Haematologica
Hematology
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
